Published in Br J Pharmacol on March 01, 1991
Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest (1992) 2.26
Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest (1998) 1.68
Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am J Pathol (2003) 1.42
Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut (2001) 1.29
Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats. Br J Pharmacol (2007) 1.12
Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am J Pathol (1998) 1.01
Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest (1993) 1.01
Sildenafil prevents indomethacin-induced gastropathy in rats: role of leukocyte adherence and gastric blood flow. Br J Pharmacol (2005) 0.98
Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat. Br J Pharmacol (2006) 0.96
Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br J Pharmacol (2002) 0.94
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits. Br J Pharmacol (1993) 0.83
Evidence that endogenous nitric oxide modulates plasma fibrinogen levels in the rat. Br J Pharmacol (1996) 0.79
The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit. Br J Pharmacol (1992) 0.79
Hypoxia attenuates effector-target cell interaction in the airway and pulmonary vascular compartment. Clin Exp Immunol (2007) 0.77
Sulfated-polysaccharide fraction from red algae Gracilaria caudata protects mice gut against ethanol-induced damage. Mar Drugs (2011) 0.77
Increased expired NO and roles of CO2 and endogenous NO after venous gas embolism in rabbits. Eur J Appl Physiol (2006) 0.77
Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals. Sleep Disord (2015) 0.77
Attenuation by prolonged nitric oxide synthase inhibition of the enhancement of fibrinolysis caused by environmental stress in the rat. Br J Pharmacol (1996) 0.76
Role of endogenous nitric oxide on PAF-induced vascular and respiratory effects. Mediators Inflamm (1995) 0.75
New perspectives of nitric oxide donors in cardiac arrest and cardiopulmonary resuscitation treatment. Heart Fail Rev (2014) 0.75
Nasal hyperreactivity and inflammation in allergic rhinitis. Mediators Inflamm (1996) 0.75
The effect of Nomega-nitro-L-arginine methyl ester and L-arginine on lung injury induced by abdominal aortic occlusion-reperfusion. Surg Today (2007) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 13.19
L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol (1990) 7.27
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 4.55
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A (1990) 3.98
Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J (1989) 3.70
Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol (1986) 3.66
Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem (1989) 3.42
L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol (1990) 2.84
Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci U S A (1977) 2.83
Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci U S A (1989) 2.08
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet (1990) 2.04
Kinetic characteristics of nitric oxide synthase from rat brain. Biochem J (1990) 2.00
In vivo EDRF activity influences platelet function. Br J Pharmacol (1988) 1.42
An in vivo model for studying platelet aggregation and disaggregation. Thromb Haemost (1982) 1.33
Endothelial nitric oxide generating enzyme(s) in the bovine aorta: subcellular location and metabolic characterization. J Pharmacol Exp Ther (1990) 1.28
Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse. Circ Res (1987) 1.23
Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo. Eur J Pharmacol (1988) 1.21
Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets. Br J Pharmacol (1990) 0.94
Radioisotopic model for investigating thromboembolism in the rabbit. J Pharmacol Methods (1990) 0.93
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol (1990) 2.84
Inflammatory mediators of asthma: an update. Pharmacol Rev (1998) 2.54
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Inflammatory mediators and asthma. Pharmacol Rev (1988) 2.17
The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol (2002) 2.05
Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr (1988) 1.96
Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) (1977) 1.92
Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci (2008) 1.84
Risk of pulmonary complications after elective abdominal surgery. Chest (1996) 1.84
Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol (2006) 1.68
Appendicitis: why so complicated? Analysis of 5755 consecutive appendectomies. Am Surg (2000) 1.64
Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels. Br J Pharmacol (1988) 1.59
Therapeutic uses of heparin beyond its traditional role as an anticoagulant. Trends Pharmacol Sci (1995) 1.58
Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol (1996) 1.57
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport (1994) 1.56
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. Br J Pharmacol (1983) 1.53
The platelet in asthma. Lancet (1984) 1.50
Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis. Br J Pharmacol (1978) 1.47
Is exploratory celiotomy necessary for all patients with truncal stab wounds? Arch Surg (1990) 1.47
Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol (1993) 1.47
Platelet-activating factor: a possible mediator of the dual response to allergen? Clin Allergy (1984) 1.45
Prospective clinical trial of a human tumor cloning system. Cancer Res (1983) 1.44
The incidence and risk of early postoperative small bowel obstruction. A cohort study. Am J Surg (1987) 1.44
A survey of the content of BSc courses in pharmacology in UK universities--is it time for a core curriculum? Trends Pharmacol Sci (1998) 1.43
Anatomy of a defective barrier: sequential glove leak detection in a surgical and dental environment. Crit Care Med (1992) 1.42
A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol (1998) 1.41
Pathways of prostaglandin F2alpha metabolism in mammalian kidneys. Br J Pharmacol (1977) 1.40
Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Arch Surg (1992) 1.34
Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med (1995) 1.34
Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol (1999) 1.34
An in vivo model for studying platelet aggregation and disaggregation. Thromb Haemost (1982) 1.33
An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus. Br J Pharmacol (1992) 1.33
Burden and cost of imported infections admitted to infectious diseases units in England and Wales in 1998 and 1999. J Infect (2004) 1.28
A randomized clinical trial of total parenteral nutrition in malnourished surgical patients: the rationale and impact of previous clinical trials and pilot study on protocol design. Am J Clin Nutr (1988) 1.26
Anti-inflammatory steroids reduce tissue PG synthetase activity and enhance PG breakdown. Nature (1980) 1.22
Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol (1988) 1.21
Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet (1987) 1.21
Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo. Eur J Pharmacol (1988) 1.21
PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils. Microcirc Endothelium Lymphatics (1984) 1.19
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin. Br J Dermatol (1984) 1.17
Acute cholecystitis in the diabetic. A case-control study of outcome. Arch Surg (1988) 1.15
Synergistic anti-nociceptive effect of L-NG-nitro arginine methyl ester (L-NAME) and flurbiprofen in the mouse. Br J Pharmacol (1992) 1.14
Adenosine receptors and asthma. Br J Pharmacol (2008) 1.14
Role of sex hormones in allergic inflammation in mice. Clin Exp Allergy (2007) 1.14
Complicated presentations of groin hernias. Am J Surg (1991) 1.13
Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. Br J Dermatol (1985) 1.13
Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle. Br J Pharmacol (1980) 1.11
The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. Eur J Pharmacol (1988) 1.11
Nutritional status: importance in predicting wound-healing after amputation. J Bone Joint Surg Am (1984) 1.08
Pathophysiological states modify levels in rat plasma of factors which inhibit synthesis and enhance breakdown of PG. Nature (1980) 1.08
Anode/cathode make and break phenomena in a model of defibrillation. IEEE Trans Biomed Eng (1999) 1.08
Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol (2002) 1.08
A multi-country Salmonella Enteritidis phage type 14b outbreak associated with eggs from a German producer: 'near real-time' application of whole genome sequencing and food chain investigations, United Kingdom, May to September 2014. Euro Surveill (2015) 1.07
Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system. Neuroscience (2006) 1.07
7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci (1995) 1.07
Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am J Respir Crit Care Med (1996) 1.07
The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br J Pharmacol (2001) 1.05
A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin. Br J Pharmacol (2000) 1.05
Antitussive drugs--past, present, and future. Pharmacol Rev (2014) 1.05
Nitroparacetamol exhibits anti-inflammatory and anti-nociceptive activity. Br J Pharmacol (2000) 1.04
Effect of capsaicin on PAF-induced bronchial hyperresponsiveness and pulmonary cell accumulation in the rabbit. Br J Pharmacol (1991) 1.04
The effect of platelet activating factor on pulmonary beta-adrenoceptors. Br J Pharmacol (1987) 1.03
The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and heightened airway responsiveness in allergic rabbits. Am Rev Respir Dis (1990) 1.03
Theophylline--an immunomodulatory role in asthma? Am Rev Respir Dis (1993) 1.03
Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm Res (2008) 1.02
Complications of needle catheter jejunostomy in 2,022 consecutive applications. Am J Surg (1995) 1.02
Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol (1998) 1.02
An overview of the biological significance of endogenous gases: new roles for old molecules. Biochem Soc Trans (2007) 1.01
The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney. Br J Pharmacol (1989) 1.01
Operative management of diverticular emergencies: strategies and outcomes. Arch Surg (2000) 1.01
Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis. Br J Pharmacol (1995) 1.00
Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009-2011. Euro Surveill (2012) 1.00
Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lung. Br J Pharmacol (1986) 0.99
In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci U S A (1994) 0.99
Inhibition of bradykinin-induced bronchoconstriction in the guinea-pig by a synthetic B2 receptor antagonist. Br J Pharmacol (1989) 0.99
Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation. Ann Surg (1985) 0.99
The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects. Eur Respir J (1997) 0.98
Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol (1985) 0.98
Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent? Trends Biotechnol (1995) 0.98
Early postoperative jejunal feeding of elemental diet in gastrointestinal surgery. Am Surg (1981) 0.98
A comparison of the effect of nitroparacetamol and paracetamol on liver injury. Br J Pharmacol (2001) 0.97
Human plasma contains prostaglandin 'reciprocal coupling factor'. Eur J Pharmacol (1980) 0.97
Accumulation of platelets and eosinophils in baboon lung after paf-acether challenge. Inhibition by ketotifen. Am Rev Respir Dis (1988) 0.97
PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle. Br J Pharmacol (1990) 0.97
Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology (1998) 0.97
Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat. Br J Pharmacol (2006) 0.96
The involvement of platelets in non-thrombotic processes. Trends Pharmacol Sci (1988) 0.95
The effect of inhaled heparin and related glycosaminoglycans on allergen-induced eosinophil infiltration in guinea-pigs. Pulm Pharmacol (1997) 0.95
The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br J Pharmacol (1995) 0.95
Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets. Br J Pharmacol (1990) 0.94
A nociceptive-intensity-dependent role for hydrogen sulphide in the formalin model of persistent inflammatory pain. Neuroscience (2008) 0.94
Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma? Eur J Pharmacol (1982) 0.94
The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration. J Lipid Mediat (1993) 0.94
RSD931, a novel anti-tussive agent acting on airway sensory nerves. Br J Pharmacol (2003) 0.94
Continuous monitoring of plasma protein extravasation and cell accumulation in vivo. Br J Dermatol (1983) 0.93
Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits. Br J Pharmacol (1993) 0.93
Radioisotopic model for investigating thromboembolism in the rabbit. J Pharmacol Methods (1990) 0.93
Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J (1995) 0.92